Kolexia
Bodet-Milin Caroline
Médecine nucléaire
Hôpital Hôtel-Dieu Nantes
Nantes, France
171 Activités
17 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Myélome multiple Lymphome B diffus à grandes cellules Lymphome B Maladie résiduelle Lymphome à cellules du manteau Maladie de Hodgkin Tumeurs à plasmocytes Métastase tumorale

Industries

BMS
3 collaboration(s)
Dernière en 2020
ADVANCED ACCELERATOR APPLICATIONS
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

LyMa101: Phase II Study to Evaluate the Efficacy of Upfront Obinutuzumab in Mantle Cell Lymphoma Patients Treated by DHAP Followed by Autologous Transplantation Plus Obinutuzumab Maintenance Then MRD Driven Maintenance
Essai Clinique (The Lymphoma Academic Research Organisation)   13 mars 2024
PentiMyelo: Exploratory Study Evaluating the Relevance of [68Ga]Ga -PentixaFor for Initial Staging and Therapeutic Evaluation of Symptomatic Multiple Myeloma Patients in First Line Treatment
Essai Clinique (CHU Nantes)   13 novembre 2023
Prognostic Value of F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   09 novembre 2023
Low Tmtv Influences Response and Outcomes in R/R DLBCL 3L+ Patients Treated with CAR-T Cells : First Results of FDG-PET/CT Analysis in the French Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.
Scientific reports   24 octobre 2023
Validation of the ΔSUV for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   21 septembre 2023
Multiple myeloma mimicking metastatic skull base paraganglioma in GaGa-DOTATOC-PET/CT and 2- FFDG-PET/CT imaging.
European journal of nuclear medicine and molecular imaging   30 juin 2023
Long term follow-up of untreated/relapsing MCL patients with the Ibrutinib, obinutuzumab, and venetoclax combination
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Hybrid simultaneous whole-body 2- FFDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value results.
European radiology   06 avril 2023
2- 18 FFDG PET/CT Flare-up Phenomena Following T-Cell Engager Bispecific Antibody in Multiple Myeloma.
Clinical nuclear medicine   06 mars 2023